CASI Pharmaceuticals
CASI
#9764
Rank
C$50.03 M
Marketcap
$3.23
Share price
0.67%
Change (1 day)
-48.27%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -C$40.2 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$22.05 Million. In 2023 the company made an earning of -C$38.03 Million, an increase over its 2022 earnings that were of -C$53.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$40.2 Million5.71%
2023 -C$38.03 Million-29.55%
2022 -C$53.97 Million4.43%
2021 -C$51.68 Million-24.56%
2020 -C$68.51 Million4.74%
2019 -C$65.41 Million65.13%
2018 -C$39.61 Million155.07%
2017 -C$15.53 Million13.93%
2016 -C$13.64 Million31.18%
2015 -C$10.4 Million-72.5%
2014 -C$37.78 Million356.62%
2013 -C$8.28 Million-60.55%
2012 -C$20.98 Million218.41%
2011 -C$6.59 Million0.74%
2010 -C$6.54 Million-32.54%
2009 -C$9.7 Million-66.98%
2008 -C$29.36 Million-14.22%
2007 -C$34.22 Million7.04%
2006 -C$31.97 Million27.95%
2005 -C$24.99 Million4.51%
2004 -C$23.91 Million-15.84%
2003 -C$28.41 Million-55.29%
2002 -C$63.54 Million-34.05%
2001 -C$96.33 Million31.73%
2000 -C$73.13 Million31.56%
1999 -C$55.59 Million145.56%
1998 -C$22.64 Million76.4%
1997 -C$12.84 Million36.92%
1996 -C$9.38 Million